Epi 712 – Intermediate Epidemiology Patty Kissinger, Ph.D. (Prof) Jeff Kopicko, MSPH (TA) Meg...

49
Epi 712 – Intermediate Epidemiology Patty Kissinger, Ph.D. (Prof) Jeff Kopicko, MSPH (TA) Meg O’Brien, MPH (TA)

Transcript of Epi 712 – Intermediate Epidemiology Patty Kissinger, Ph.D. (Prof) Jeff Kopicko, MSPH (TA) Meg...

Page 1: Epi 712 – Intermediate Epidemiology Patty Kissinger, Ph.D. (Prof) Jeff Kopicko, MSPH (TA) Meg O’Brien, MPH (TA)

Epi 712 – Intermediate Epidemiology

Patty Kissinger, Ph.D. (Prof)

Jeff Kopicko, MSPH (TA)

Meg O’Brien, MPH (TA)

Page 2: Epi 712 – Intermediate Epidemiology Patty Kissinger, Ph.D. (Prof) Jeff Kopicko, MSPH (TA) Meg O’Brien, MPH (TA)

Objectives

• To discuss course logistics

• To review the basics of Epidemiology

• To describe the difference between descriptive and analytic epidemiology

• To discuss the basic study designs

• To discuss criteria for causality

• Readings: Szklo and Nieto Chapter 1

Page 3: Epi 712 – Intermediate Epidemiology Patty Kissinger, Ph.D. (Prof) Jeff Kopicko, MSPH (TA) Meg O’Brien, MPH (TA)

Definition of Epidemiology

• The study of the distribution and determinants of health-related states or events in specified populations and the application of this study to control health problems.

Page 4: Epi 712 – Intermediate Epidemiology Patty Kissinger, Ph.D. (Prof) Jeff Kopicko, MSPH (TA) Meg O’Brien, MPH (TA)

Classifications of Epidemiology

• Descriptive –– Used to describe person, place and time– Used to generate hypotheses

• Analytic– Used to test hypotheses

Page 5: Epi 712 – Intermediate Epidemiology Patty Kissinger, Ph.D. (Prof) Jeff Kopicko, MSPH (TA) Meg O’Brien, MPH (TA)

Uses of Epidemiology• Determine etiologic or causal factors• Describe factors associate with adverse

conditions• Community diagnosis of distribution of

diseases• Predicting disease occurrence, impact

and distribution• Estimating individuals risk of disease

Page 6: Epi 712 – Intermediate Epidemiology Patty Kissinger, Ph.D. (Prof) Jeff Kopicko, MSPH (TA) Meg O’Brien, MPH (TA)

Uses of Epidemiology (con’t)

• Evaluating therapeutic and intervention activities

• Measurement of efficacy of health measures

• Studying of historical disease• Identifying disease syndromes• Planning for current health needs• Predicting future needs.

Page 7: Epi 712 – Intermediate Epidemiology Patty Kissinger, Ph.D. (Prof) Jeff Kopicko, MSPH (TA) Meg O’Brien, MPH (TA)

Person, Place, Time

• Person - age, sex, race/ethnicity, martial status, occupation, education, socio-economic status

• Place - hospital-based, community-based, regional

• Time - seasonal, secular, am/pm/noc

Page 8: Epi 712 – Intermediate Epidemiology Patty Kissinger, Ph.D. (Prof) Jeff Kopicko, MSPH (TA) Meg O’Brien, MPH (TA)

Examples of descriptive epidemiologic findings

Page 9: Epi 712 – Intermediate Epidemiology Patty Kissinger, Ph.D. (Prof) Jeff Kopicko, MSPH (TA) Meg O’Brien, MPH (TA)

Gonorrhea (cases per 100,000)The Hidden Epidemic, Institute of Medicine, 1997

0 50 100 150 200

U.S.

England

Canada

Autstralia

Denmark

Germany

Sweden

Page 10: Epi 712 – Intermediate Epidemiology Patty Kissinger, Ph.D. (Prof) Jeff Kopicko, MSPH (TA) Meg O’Brien, MPH (TA)

Possible interpretations

• May be confounded by detection bias (i.e. More people get tested in U.S and policy in Europe is to just treat syndromically and not test)

• May be reporting bias (gonorrhea is not reported as well in countries other than the U.S.)

• The U.S. people are more likely to have unprotected sex.

Page 11: Epi 712 – Intermediate Epidemiology Patty Kissinger, Ph.D. (Prof) Jeff Kopicko, MSPH (TA) Meg O’Brien, MPH (TA)

Abnormal Pap results by age (U.S., 1991-1993, NBCCEDP)

0

2

4

6

8

10

12

14

< 30 30-39 40-49 50-59 60-69 >69

Page 12: Epi 712 – Intermediate Epidemiology Patty Kissinger, Ph.D. (Prof) Jeff Kopicko, MSPH (TA) Meg O’Brien, MPH (TA)

Possible interpretations

• Interpretation is difficult because we don’t know if it is a rate or just cases reported

• If it is cases, then it is not interpretable without know the population distribution (i.e. denominator information)

• If it is rates, then women < 30 are at highest risk (maybe due to Human Papillomavirus)

Page 13: Epi 712 – Intermediate Epidemiology Patty Kissinger, Ph.D. (Prof) Jeff Kopicko, MSPH (TA) Meg O’Brien, MPH (TA)

By 12th grade, nearly 70 percent of high school students have had sexual intercourse (YRBS,

1993)

3846

58

68

0

10

20

30

40

50

60

70

80

9th 10th 11th 12th

Page 14: Epi 712 – Intermediate Epidemiology Patty Kissinger, Ph.D. (Prof) Jeff Kopicko, MSPH (TA) Meg O’Brien, MPH (TA)

Possible Interpretation

• Again, we don’t know if it is rates or cases

• It is prevalence data, and we don’t know when the first sexual act occurred, but we know that 38% of the 9th graders already had sex so, sex education starting at high school is too late.

Page 15: Epi 712 – Intermediate Epidemiology Patty Kissinger, Ph.D. (Prof) Jeff Kopicko, MSPH (TA) Meg O’Brien, MPH (TA)

Definitions• Endemic - a persistent level of occurrence

with low to moderate disease level• Hyper-endemic - persistently high level of

occurrence• Sporadic - irregular • Epidemic (outbreak)- occurrence of disease

is in excess of expected levels• Pandemic - epidemic spreads over several

countries or continents

Page 16: Epi 712 – Intermediate Epidemiology Patty Kissinger, Ph.D. (Prof) Jeff Kopicko, MSPH (TA) Meg O’Brien, MPH (TA)

Role of an Epidemiologist

• Surveillance

• Outbreak investigation

• Hypothesis testing

• Evaluation

• Communication

Page 17: Epi 712 – Intermediate Epidemiology Patty Kissinger, Ph.D. (Prof) Jeff Kopicko, MSPH (TA) Meg O’Brien, MPH (TA)

Surveillance

Page 18: Epi 712 – Intermediate Epidemiology Patty Kissinger, Ph.D. (Prof) Jeff Kopicko, MSPH (TA) Meg O’Brien, MPH (TA)

The importance of surveillance for Management

Purposes of surveillance• setting of priorities• planning and allocating resources for service• defining population subgroups and risky behaviors for

targeted interventions• directing public health policy• informing diagnostic and therapeutic practice• evaluation of interventions• stimulating further research

Page 19: Epi 712 – Intermediate Epidemiology Patty Kissinger, Ph.D. (Prof) Jeff Kopicko, MSPH (TA) Meg O’Brien, MPH (TA)

Characteristics of Surveillance

• Purpose is to monitor trends of disease

• Usually large data sets

• Can be used to identify persons at risk for a disease

Page 20: Epi 712 – Intermediate Epidemiology Patty Kissinger, Ph.D. (Prof) Jeff Kopicko, MSPH (TA) Meg O’Brien, MPH (TA)
Page 21: Epi 712 – Intermediate Epidemiology Patty Kissinger, Ph.D. (Prof) Jeff Kopicko, MSPH (TA) Meg O’Brien, MPH (TA)

Possible Interpretations

• This is a better slide because we know it is rates.

• We can probably draw a conclusion that the risk of breast cancer increases with age.

Page 22: Epi 712 – Intermediate Epidemiology Patty Kissinger, Ph.D. (Prof) Jeff Kopicko, MSPH (TA) Meg O’Brien, MPH (TA)
Page 23: Epi 712 – Intermediate Epidemiology Patty Kissinger, Ph.D. (Prof) Jeff Kopicko, MSPH (TA) Meg O’Brien, MPH (TA)

Possible interpretations

• We know that the rates of diabetes is going up, we assume it is type II or adult onset.

• We don’t what factors are related but we could hypothesis that obesity is increasing or there is an aging of the cohort since these are not age adjusted

Page 24: Epi 712 – Intermediate Epidemiology Patty Kissinger, Ph.D. (Prof) Jeff Kopicko, MSPH (TA) Meg O’Brien, MPH (TA)
Page 25: Epi 712 – Intermediate Epidemiology Patty Kissinger, Ph.D. (Prof) Jeff Kopicko, MSPH (TA) Meg O’Brien, MPH (TA)
Page 26: Epi 712 – Intermediate Epidemiology Patty Kissinger, Ph.D. (Prof) Jeff Kopicko, MSPH (TA) Meg O’Brien, MPH (TA)

Possible interpretations

• If you look at the last two slides and imagine them being super-imposed upon one another you can see that physical inactivity and cardiovascular disease co-vary.

• You could hypothesis that physical inactivity may be associated with cardio-vascular disease

Page 27: Epi 712 – Intermediate Epidemiology Patty Kissinger, Ph.D. (Prof) Jeff Kopicko, MSPH (TA) Meg O’Brien, MPH (TA)
Page 28: Epi 712 – Intermediate Epidemiology Patty Kissinger, Ph.D. (Prof) Jeff Kopicko, MSPH (TA) Meg O’Brien, MPH (TA)

Possible interpretations

• There does seem to be a trend for an increase in smoking among teenagers

• A statistical test, such as a Chi-square test for trends would better help you to decide.

Page 29: Epi 712 – Intermediate Epidemiology Patty Kissinger, Ph.D. (Prof) Jeff Kopicko, MSPH (TA) Meg O’Brien, MPH (TA)
Page 30: Epi 712 – Intermediate Epidemiology Patty Kissinger, Ph.D. (Prof) Jeff Kopicko, MSPH (TA) Meg O’Brien, MPH (TA)

Possible interpretations

• We should probably be most worried about the heterosexual community because it is steadily increasing and it is a broader base of the population (~90% of the population)

• This does not tell us anything about incidence, it is only a description of prevalence.

Page 31: Epi 712 – Intermediate Epidemiology Patty Kissinger, Ph.D. (Prof) Jeff Kopicko, MSPH (TA) Meg O’Brien, MPH (TA)

Confounding

E D

C

E=exposure

C=confounder

D=disease

Page 32: Epi 712 – Intermediate Epidemiology Patty Kissinger, Ph.D. (Prof) Jeff Kopicko, MSPH (TA) Meg O’Brien, MPH (TA)

Birth Cohorts

• Age is a strong risk factor for many health outcomes

• For many diseases, exposures have a cumulative effect that are expressed over long periods of time.

Page 33: Epi 712 – Intermediate Epidemiology Patty Kissinger, Ph.D. (Prof) Jeff Kopicko, MSPH (TA) Meg O’Brien, MPH (TA)
Page 34: Epi 712 – Intermediate Epidemiology Patty Kissinger, Ph.D. (Prof) Jeff Kopicko, MSPH (TA) Meg O’Brien, MPH (TA)
Page 35: Epi 712 – Intermediate Epidemiology Patty Kissinger, Ph.D. (Prof) Jeff Kopicko, MSPH (TA) Meg O’Brien, MPH (TA)
Page 36: Epi 712 – Intermediate Epidemiology Patty Kissinger, Ph.D. (Prof) Jeff Kopicko, MSPH (TA) Meg O’Brien, MPH (TA)
Page 37: Epi 712 – Intermediate Epidemiology Patty Kissinger, Ph.D. (Prof) Jeff Kopicko, MSPH (TA) Meg O’Brien, MPH (TA)
Page 38: Epi 712 – Intermediate Epidemiology Patty Kissinger, Ph.D. (Prof) Jeff Kopicko, MSPH (TA) Meg O’Brien, MPH (TA)
Page 39: Epi 712 – Intermediate Epidemiology Patty Kissinger, Ph.D. (Prof) Jeff Kopicko, MSPH (TA) Meg O’Brien, MPH (TA)

Definitions

• Age effect – Change in the rate of a condition according to age irrespective of birth cohort and calendar time.

• Cohort effect – Change in the rate of a condition according to year of birth, irrespective of age and calendar time.

• Period effect – Change in the rate of a condition affecting an entire population at some point in time, irrespective of age and cohort effect

Page 40: Epi 712 – Intermediate Epidemiology Patty Kissinger, Ph.D. (Prof) Jeff Kopicko, MSPH (TA) Meg O’Brien, MPH (TA)

Surveillance Systems

• Are active or passive

• Can be for a whole population or for a selected group (sentinel)

Page 41: Epi 712 – Intermediate Epidemiology Patty Kissinger, Ph.D. (Prof) Jeff Kopicko, MSPH (TA) Meg O’Brien, MPH (TA)

Outbreak Investigation

Page 42: Epi 712 – Intermediate Epidemiology Patty Kissinger, Ph.D. (Prof) Jeff Kopicko, MSPH (TA) Meg O’Brien, MPH (TA)

John Snow (The Father of Field Epidemiology) Cholera Outbreak Investigation 1854

Page 43: Epi 712 – Intermediate Epidemiology Patty Kissinger, Ph.D. (Prof) Jeff Kopicko, MSPH (TA) Meg O’Brien, MPH (TA)
Page 44: Epi 712 – Intermediate Epidemiology Patty Kissinger, Ph.D. (Prof) Jeff Kopicko, MSPH (TA) Meg O’Brien, MPH (TA)
Page 45: Epi 712 – Intermediate Epidemiology Patty Kissinger, Ph.D. (Prof) Jeff Kopicko, MSPH (TA) Meg O’Brien, MPH (TA)

Possible Interpretations

• For both the community water sources (representing the poorer community) and individual home water sources (representing the higher socio-economic groups), Southwark rates were greater.

• Intervention should be started there.

Page 46: Epi 712 – Intermediate Epidemiology Patty Kissinger, Ph.D. (Prof) Jeff Kopicko, MSPH (TA) Meg O’Brien, MPH (TA)
Page 47: Epi 712 – Intermediate Epidemiology Patty Kissinger, Ph.D. (Prof) Jeff Kopicko, MSPH (TA) Meg O’Brien, MPH (TA)

Outbreak investigations

• A good idea to plot out the cases (better rates) and then determine when interventions were implemented to see if any helped.

Page 48: Epi 712 – Intermediate Epidemiology Patty Kissinger, Ph.D. (Prof) Jeff Kopicko, MSPH (TA) Meg O’Brien, MPH (TA)

Criteria for Causality• Strength of association - larger ratio between diseased and

non diseased greater the likelihood of causation• Biological credibility – the association has to make sense

biologically• Consistency of findings - association found in one study is

found in others.• Dose-response - with increasing levels of exposure to the

factor, a corresponding rise in occurrence of disease occurs• Specificity - The extent to which the occurrence of a variable

can be used to predict the occurrence of an outcome.• Time sequence- exposure precedes the disease

Page 49: Epi 712 – Intermediate Epidemiology Patty Kissinger, Ph.D. (Prof) Jeff Kopicko, MSPH (TA) Meg O’Brien, MPH (TA)

Study Designs

Descriptive Analytic Experimental

correlational

case report/case series

cross-sectional

case control

cohort

clinical trial

community trial